This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thomson Reuters And Imperial College Celebrate Open Innovation In Big Data

Stocks in this article: TRI

LONDON, Nov. 19, 2013 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the winners of the Thomson Reuters Award for Innovation in Big Data, part of an ongoing collaboration with The Imperial College of Science, Technology and Medicine of London to drive scientific innovation and research in the life sciences. This collaboration was designed to explore innovative new technologies to better manage and interpret the volume and diversity of data generated in pharmaceutical and clinical research environments, while providing Imperial College students with real-world experience as they contribute to Thomson Reuters driving innovation. The award was presented to the students who demonstrated the best technical applications, specifically related to data modeling and integration, visualization, and analytics.

(Photo:  http://photos.prnewswire.com/prnh/20131119/NY19147)

The award, presented on November 13 at the Thomson Reuters Hatton Garden office in London, was given to four Imperial College Masters students: Panagiotis Tzirakis, Michal Bachman, Bernardo Lemos Caldas and Paul Williams for their significant contributions to projects focused on data integration, analytics, visual integration, linked data, algorithms, machine learning and text mining. The winners received £500 each and were chosen from among 167 students.

"Our ongoing relationship with Thomson Reuters Life Sciences division has proven to be mutually beneficial," said William Knottenbelt, director for Imperial College. "Our students gain valuable insight and experience into cutting-edge research through their placements with Thomson Reuters, while also offering fresh perspectives and ideas to provide innovative solutions to stakeholders in the life science industry."

"We are pleased to be working with Imperial College and supporting future generations of computer and data scientists," said Jon Brett-Harris, managing director of Thomson Reuters Life Sciences. "These Awards are recognition of the innovative work these students are doing to help develop new technologies that integrate and interpret the large volumes of data generated in the pharmaceutical and healthcare industries."

The Thomson Reuters Award for Innovation in Big Data is part of the company's continued efforts to drive innovation for better managing Big Data in life sciences, specifically by converting large amounts of content or data into meaningful and accessible Little Data. To learn more about this approach, download the whitepaper, Big Data and the Needs of the Pharma Industry.  

Thomson Reuters  Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minn., Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to www.thomsonreuters.com.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,686.57 +13.97 0.08%
S&P 500 2,054.66 +2.84 0.14%
NASDAQ 4,767.9050 +10.0260 0.21%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs